IWC
IRWD icon

Integrated Wealth Concepts’s Ironwood Pharmaceuticals IRWD Stock Holding History

Integrated Wealth Concepts’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.8K Sell
15,863
-12,709
-44% -$49K ﹤0.01% 3149
2026
Q1 		$100K Buy
28,572
+17,136
+150% +$70.2K ﹤0.01% 2176
2025
Q4 		$38.5K Sell
11,436
-7,859
-41% -$20.4K ﹤0.01% 1584
2025
Q3 		$25.3K Buy
19,295
+3,406
+21% +$3.52K ﹤0.01% 1967
2025
Q2 		$11.4K Buy
+15,889
New +$12.5K ﹤0.01% 1896

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Integrated Wealth Concepts's IRWD Position: Q2 2026 in Review

Integrated Wealth Concepts reduced its Ironwood Pharmaceuticals (IRWD) stake by 44% in Q2 2026, selling an estimated $49K and leaving 15,863 shares worth $66.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3149.

Integrated Wealth Concepts first reported a position in IRWD in Q2 2025 and has held it in 5 quarters since. The position peaked at $100K in Q1 2026. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Integrated Wealth Concepts held 15,863 shares of Ironwood Pharmaceuticals worth $66.8K as of Q2 2026.
  • Integrated Wealth Concepts sold 12,709 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $49K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #3149 holding.
  • Integrated Wealth Concepts first reported a position in Ironwood Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • Integrated Wealth Concepts's Ironwood Pharmaceuticals position peaked at $100K in Q1 2026.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.